To comply with the new EU regulations: tissue engineering of meniscus combining fresh cells with the Chondro-Gide® (VN) membrane

Schrift Standard Fett
Login

Forschungsstelle

INNOSUISSE

Projektnummer

8636.1;4 LSPP-LS

Projekttitel

To comply with the new EU regulations: tissue engineering of meniscus combining fresh cells with the Chondro-Gide® (VN) membrane

Projekttitel Englisch

To comply with the new EU regulations: tissue engineering of meniscus combining fresh cells with the Chondro-Gide® (VN) membrane

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Kurzbeschreibung	-	-	-
Abstract	-	-	-

Erfasste Texte

Kategorie	Text
Kurzbeschreibung (Englisch)	To comply with the new EU regulations: tissue engineering of meniscus combining fresh cells with the Chondro-Gide® (VN) membrane
Abstract (Englisch)	The project investigates possibilities to establish ChondroGide® for meniscal repair. The goals include improving meniscus regeneration via combined application of cells and ChondroGide®VN using two approaches: synovial membrane and mesenchymal stem cells derived from bone marrow or synovium. The procedure will be within the surgical operation time frame to conform to the new EU regulations for cell-based therapies. Improving chondrogenic conductivity of ChondroGide®VN will also be tested. Results will provide data for initiation of clinical trials.

Kategorie

Text

Kurzbeschreibung
(Englisch)

To comply with the new EU regulations: tissue engineering of meniscus combining fresh cells with the Chondro-Gide® (VN) membrane

Abstract
(Englisch)

The project investigates possibilities to establish ChondroGide® for meniscal repair. The goals include improving meniscus regeneration via combined application of cells and ChondroGide®VN using two approaches: synovial membrane and mesenchymal stem cells derived from bone marrow or synovium. The procedure will be within the surgical operation time frame to conform to the new EU regulations for cell-based therapies. Improving chondrogenic conductivity of ChondroGide®VN will also be tested. Results will provide data for initiation of clinical trials.